GlassScriptPhysician profile
Lydia Savic
NPI 1669571170
$1,942.23
in general payments reported to CMS, 2019-2025
22 companies · $19.88 in 2025
The $19.88 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $457 · 2021: $644 · 2022: $192 · 2023: $59.58 · 2025: $19.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $597.14 | 2019-2023 | Otezla, Repatha |
| Pfizer INC. | $293.52 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $143.73 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $115.79 | 2019-2022 | |
| Novo Nordisk INC | $111.57 | 2019-2022 | |
| Bausch Health US, LLC | $109.31 | 2020-2021 | |
| Abbvie INC. | $87.25 | 2021-2022 | |
| Lilly USA, LLC | $85.59 | 2020-2023 | Mounjaro |
| Horizon Therapeutics Plc | $79.91 | 2020-2021 | |
| Dexcom, INC. | $48.98 | 2021 | |
| Collegium Pharmaceutical, INC. | $40.31 | 2021 | |
| Janssen Pharmaceuticals, INC | $34.28 | 2021 | |
| Sanofi-Aventis U.S. LLC | $29.66 | 2019 | |
| Mylan Specialty L.P. | $26.59 | 2021 | |
| Allergan, INC. | $26.49 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $19.88 | 2025 | Hizentra |
| Shire North American Group INC | $18.24 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.19 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.46 | 2021 | |
| Orthofix Medical, INC. | $13.81 | 2021 | |
| Biodelivery Sciences International, INC. | $13.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Savic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.